Epitope Mapping Services

We use a unique pipeline combining our own AI models and docking-based methods to predict the amino-acid patches on the antigen most likely targeted by the antibody (and the corresponding antibody interface on the other side). We can generate ~10⁹ docking poses and deliver the top 30 poses.

A combination. We can map directly from sequences, or use client-provided / publicly available structures.

Epitopes can be linear (continuous sequence) or conformational (distant residues brought together in 3D). Our approach predicts amino-acid patches and can leverage 3D structures, supporting both epitope types.

At minimum, we can work from sequences. If available, we can also use client-provided or publicly available structures. We also ask customers for as much biological information as possible upstream to ensure consistency between their data and our results.

Yes — we can identify epitope regions without prior experimental or published data.

Our Epitope mapping service is suitable for therapeutic antibody development, diagnostic antibody generation and research antibodies.

The average turnaround time is around 2 weeks.

We provide epitope & paratope mapping, with predicted amino-acid patches / residues most likely involved at the interface. We can also characterize interaction types (hydrophobic, H-bonds, salt bridges, Van der Waals, etc.) and suggest mutations to neutralize or enhance interactions. We typically converge on a reliable epitope of ~10 key residues after iteration.

We recommend targeted validation: introduce mutations in predicted regions, synthesize genes for each variant, produce recombinantly, then confirm experimentally in flow cytometry. A second round of mutation can be done to definitively confirm the predicted epitope/paratope.

HDX-MS is available, but it is significantly more expensive and less reliable for proteins with unstructured regions due to fast deuterium exchange.

Of course, we can support you with our wide range of antibody engineering services, including: AI-driven affinity maturation, AI-powered humanization and AI developability improvement. 

Explore our antibody optimization services

You remain the full owner of your antibody. Our service is 100% IP-free, royalty-free and without restrictions.

Yes. Your dedicated PhD expert can guide you from start to finish. Our therapeutic antibody discovery services are designed to carry your project from early discovery to pre-clinical grade production and custom cell line development.